SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$17.95−1.20 (-6.27%)
Close on Nov 18, 2026Market cap $3.62BP/E –Yield –
SELLAS Life Sciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
SELLAS Life Sciences's total debt was $0 at Dec 31, 2018. For fiscal 2018 it was $0, down 100.0% from the year before. The highest annual figure on record is $16.40M in fiscal 2016.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $0 | -100.0% |
| FY2017 | Dec 31, 2017 | $10.99M | -33.0% |
| FY2016 | Dec 31, 2016 | $16.40M | +246.0% |
| FY2015 | Dec 31, 2015 | $4.74M | -43.6% |
| FY2014 | Dec 31, 2014 | $8.40M | -15.1% |
| FY2013 | Dec 31, 2013 | $9.89M | – |
| FY2012 | Dec 31, 2012 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $76.00K | -99.4% |
| Q2 FY2018 | Jun 30, 2018 | $7.78M | -40.3% |
| Q1 FY2018 | Mar 31, 2018 | $9.68M | -23.2% |
| Q4 FY2017 | Dec 31, 2017 | $10.99M | -33.0% |
| Q3 FY2017 | Sep 30, 2017 | $12.17M | -48.7% |
| Q2 FY2017 | Jun 30, 2017 | $13.03M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.40M | – |
| Q3 FY2016 | Sep 30, 2016 | $23.72M | – |
See a number that looks wrong?